The R&D on them, as well as the FDA studies on them, were done decades ago.
They charge as much as they can get away with. I think they found that point now.
No, it's a new drug because it is in a new format. The FDA isn't going to rubber stamp it without researching it, regardless of whether it's the same active ingredient+delivery method or not.
